Clinical Trials Logo

Clinical Trial Summary

The clinical investigation is designed to primarily confirm the performance of KIO015 in improving skin hydration after superficial intradermal injection. A non-treated zone (untreated hemi-face) will be used as comparator for exact evaluation of the zones between the treated and untreated ones The safety of KIO015 will also be evaluated for confirmation of initial data. For this purpose, 80 healthy subjects will be injected in half of the face. In KIO015-PLUM, healthy subjects with signs of cutaneous aging and dehydrated skin on the face will receive either one or three dermal injections: - Cohort 1: one intradermal injection session of KIO015 device on M0, to evaluate the effect of a single injection session - Cohort 2: three intradermal injection sessions of KIO015 device on M0, M1 and M2, to evaluate the effect of 3 injection sessions as performed for state-of-the-art products.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05747690
Study type Interventional
Source Kiomed Pharma
Contact
Status Active, not recruiting
Phase N/A
Start date February 1, 2023
Completion date April 4, 2024

See also
  Status Clinical Trial Phase
Completed NCT04128046 - The Effect of Platelet-rich Fibrin Matrix on Skin Rejuvenation N/A
Completed NCT04172740 - RADIESSE Injection in Perioral and Marionette Lines N/A
Not yet recruiting NCT05595525 - Laser Treatment to Improve Skin Quality N/A
Completed NCT03424161 - Multi-Center, Clinical Evaluation of the Cutera Secret RF Device N/A
Completed NCT03097835 - Evaluation of Skin Quality Improvement Phase 2